Below are the financial statements of CSPC Pharmaceutical Group, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in billions of CNY | 2024 | 2023 |
|---|---|---|
| Revenue | 29.01a | 31.45a |
| Cost of sales | -8.71a | -9.27a |
| Gross profit | 20.3a | 22.18a |
| Other income | 0.56a | 0.63a |
| Other gains or losses, net | -0.12a | -0.1a |
| Selling and distribution expenses | -8.66a | -9.14a |
| Administrative expenses | -1.08a | -1.19a |
| Research and development expenses | -5.19a | -4.83a |
| Other expenses | -0.1a | -0.1a |
| Share of results of associates | -0.05a | -0.04a |
| Share of results of joint ventures | -0.04a | -0.01a |
| Gain on deemed disposal of partial interests in an associate | 0a | 0.03a |
| Finance costs | -0.04a | -0.03a |
| Profit before tax | 5.58a | 7.39a |
| Income tax expense | -1.24a | -1.32a |
| Profit for the year | 4.34a | 6.07a |
| Profit for the year attributable to: | — | — |
| Owners of the company | 4.33a | 5.87a |
| Non-controlling interests | 0.01a | 0.2a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore CSPC Pharmaceutical Group’s data sources below and access millions more through our Disclosure Search.